OPKO Health Other Long-Term Assets 2010-2024 | OPK

OPKO Health other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
OPKO Health Annual Other Long-Term Assets
(Millions of US $)
2023 $204
2022 $204
2021 $600
2020 $600
2019 $597
2018 $643
2017 $653
2016 $650
2015 $797
2014 $799
2013 $800
2012 $14
2011 $1
2010 $0
2009 $0
OPKO Health Quarterly Other Long-Term Assets
(Millions of US $)
2024-09-30 $214
2024-06-30 $203
2024-03-31 $204
2023-12-31 $204
2023-09-30 $204
2023-06-30 $204
2023-03-31 $203
2022-12-31 $204
2022-09-30 $205
2022-06-30 $204
2022-03-31 $9
2021-12-31 $600
2021-09-30 $599
2021-06-30 $600
2021-03-31 $600
2020-12-31 $600
2020-09-30 $596
2020-06-30 $598
2020-03-31 $597
2019-12-31 $597
2019-09-30 $641
2019-06-30 $639
2019-03-31 $639
2018-12-31 $643
2018-09-30 $656
2018-06-30 $651
2018-03-31 $652
2017-12-31 $653
2017-09-30 $687
2017-06-30 $685
2017-03-31 $684
2016-12-31 $650
2016-09-30 $651
2016-06-30 $610
2016-03-31 $798
2015-12-31 $797
2015-09-30 $915
2015-06-30 $818
2015-03-31 $798
2014-12-31 $799
2014-09-30 $798
2014-06-30 $798
2014-03-31 $800
2013-12-31 $800
2013-09-30 $800
2013-06-30 $206
2013-03-31 $206
2012-12-31 $14
2012-09-30 $2
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $1
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.174B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $210.506B 96.57
Thermo Fisher Scientific (TMO) United States $202.042B 24.50
Alcon (ALC) Switzerland $44.047B 29.47
Edwards Lifesciences (EW) United States $42.914B 27.77
IDEXX Laboratories (IDXX) United States $37.709B 43.46
DexCom (DXCM) United States $35.463B 55.00
IQVIA Holdings (IQV) United States $34.295B 19.00
Mettler-Toledo (MTD) United States $27.400B 31.83
Waters (WAT) United States $22.520B 31.95
STERIS (STE) Ireland $21.977B 25.13
SONOVA HOLDING (SONVY) Switzerland $19.361B 0.00
Hologic (HOLX) United States $14.588B 15.74
Fresenius Medical Care AG KGaA (FMS) Germany $13.679B 14.04
Sysmex ADR (SSMXY) Japan $11.343B 35.57
Penumbra (PEN) United States $11.081B 100.24
Globus Medical (GMED) United States $10.896B 25.48
Masimo (MASI) United States $9.140B 44.23
Teleflex (TFX) United States $8.250B 13.16
Glaukos (GKOS) United States $6.850B 0.00
Integer Holdings (ITGR) United States $4.269B 23.96
PROCEPT BioRobotics (PRCT) United States $3.400B 0.00
Veracyte (VCYT) United States $3.050B 55.44
LivaNova (LIVN) United Kingdom $2.688B 15.52
Nihon Kohden (NHNKY) Japan $2.652B 14.49
TransMedics (TMDX) United States $2.588B 82.04
Elekta AB (EKTAY) Sweden $2.198B 19.76
Tandem Diabetes Care (TNDM) United States $2.145B 0.00
Integra LifeSciences Holdings (IART) United States $1.701B 8.89
Alphatec Holdings (ATEC) United States $1.526B 0.00
RxSight (RXST) United States $1.181B 0.00
Artivion (AORT) United States $1.167B 111.40
Pulse Biosciences (PLSE) United States $1.154B 0.00
Paragon 28 (FNA) United States $1.092B 0.00
Beta Bionics (BBNX) United States $0.883B 0.00
AxoGen (AXGN) United States $0.793B 0.00
Mesa Laboratories (MLAB) United States $0.791B 17.30
SiBone (SIBN) United States $0.733B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.718B 12.21
IRadimed (IRMD) United States $0.699B 36.76
ORTHOFIX MEDICAL INC (OFIX) United States $0.694B 0.00
Treace Medical Concepts (TMCI) United States $0.597B 0.00
OrthoPediatrics (KIDS) United States $0.569B 0.00
ClearPoint Neuro (CLPT) United States $0.452B 0.00
Delcath Systems (DCTH) United States $0.449B 0.00
Pacific Biosciences Of California (PACB) United States $0.446B 0.00
Semler Scientific (SMLR) United States $0.411B 9.04
AngioDynamics (ANGO) United States $0.408B 0.00
NeuroPace (NPCE) United States $0.404B 0.00
Tactile Systems Technology (TCMD) United States $0.351B 18.86
CVRx (CVRX) United States $0.343B 0.00
Anteris Technologies Global (AVR) Australia $0.261B 0.00
Inogen (INGN) United States $0.234B 0.00
Nevro (NVRO) United States $0.214B 0.00
Accuray (ARAY) United States $0.212B 0.00
Alpha Tau Medical (DRTS) Israel $0.192B 0.00
KORU Medical Systems (KRMD) United States $0.169B 0.00
Spectral Diagnostics (EDTXF) Canada $0.151B 0.00
Neuronetics (STIM) United States $0.135B 0.00
Sight Sciences (SGHT) United States $0.125B 0.00
Rapid Micro Biosystems (RPID) United States $0.121B 0.00
LENSAR (LNSR) United States $0.108B 0.00
Atossa Genetics (ATOS) United States $0.099B 0.00
InspireMD (NSPR) Israel $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.093B 0.00
908 Devices (MASS) United States $0.089B 0.00
Sensus Healthcare (SRTS) United States $0.085B 12.98
Lucid Diagnostics (LUCD) United States $0.082B 0.00
Vicarious Surgical (RBOT) United States $0.081B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Covalon Technologies (CVALF) Canada $0.055B 16.58
Microbot Medical (MBOT) United States $0.054B 0.00
Positron (POSC) United States $0.052B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Baird Medical Investment Holdings (BDMD) $0.029B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.021B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
WORK Medical Technology Group (WOK) China $0.014B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
Aspira Women's Health (AWH) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00